Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy.

Published in:

PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0191290

By:

• Jung, Su-Young;
• Kwon, Jaeyeol;
• Park, Seohyun;
• Jhee, Jong Hyun;
• Yun, Hae-Ryong;
• Kim, HyoungNae;
• Kee, Youn Kyung;
• Yoon, Chang-Yun;
• Chang, Tae-Ik;
• Kang, Ea Wha;
• Park, Jung Tak;
• Yoo, Tae-Hyun;
• Kang, Shin-Wook;
• Han, Seung Hyeok

Publication type:

Article